López Lago AM et al. |
Evolution of hepatorenal syndrome after orthotopic liver transplantation: comparative analysis with patients who developed acute renal failure in the early postoperative period of liver transplantation. |
2007 |
Transplant. Proc. |
pmid:17889176
|
Loinaz C et al. |
A single-centre experience with cyclosporine microemulsion versus tacrolimus in 100 randomized liver transplant recipients: midterm efficacy and safety. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750472
|
Rostaing L et al. |
Early posttransplantation renal hemodynamics in FK 506-treated kidney recipients with or without prior induction therapy. |
1998 |
Transplant. Proc. |
pmid:9636519
|
Perrakis A et al. |
Impact of the conversion of the immunosuppressive regimen from prograf to advagraf or to sirolimus in long-term stable liver transplant recipients: indications, safety, and outcome. |
2011 |
Transplant. Proc. |
pmid:22172830
|
Crespo M et al. |
De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715848
|
Sancho Calabuig A et al. |
Very low-grade proteinuria at 3 months posttransplantation is an earlier marker of graft survival. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715850
|
Kinoshita I et al. |
Immunosuppression with FK 506 insures good success of myoblast transplantation in MDX mice. |
1994 |
Transplant. Proc. |
pmid:7527978
|
Wong KM et al. |
Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study. |
2000 |
Transplant. Proc. |
pmid:11119907
|
Porayko MK et al. |
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7679835
|
Goto Y et al. |
Outcome of tacrolimus-treated renal transplantation from elderly donors. |
2000 |
Transplant. Proc. |
pmid:11119908
|
Iwasaki K et al. |
Pharmacokinetic study of FK 506 in the rat. |
1991 |
Transplant. Proc. |
pmid:1721268
|
Andersson J et al. |
FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro. |
1992 |
Transplant. Proc. |
pmid:1371621
|
Takada S et al. |
HGF prevents tacrolimus (FK 506)-induced nephrotoxicity in SHR rats. |
1996 |
Transplant. Proc. |
pmid:8623236
|
Vilalta R et al. |
Rapamycin use and rapid withdrawal of calcineurin inhibitors in pediatric renal transplantation. |
2003 |
Transplant. Proc. |
pmid:12644102
|
Monden M et al. |
A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates. |
1990 |
Transplant. Proc. |
pmid:1689904
|
Ciancio G et al. |
Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. |
2003 |
Transplant. Proc. |
pmid:12644172
|
Morell Ginestà M et al. |
Histology and immunopathology of heart and liver xenografts under low-dose tacrolimus. |
2002 |
Transplant. Proc. |
pmid:11959305
|
Cofan F et al. |
Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus. |
2002 |
Transplant. Proc. |
pmid:11959335
|
Klupp J et al. |
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636585
|
Steinmueller T et al. |
Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling technique. |
1998 |
Transplant. Proc. |
pmid:9636589
|
Miura S et al. |
The beneficial effects of FK 506 on living-related renal transplantation in presensitized recipients. |
1999 |
Transplant. Proc. |
pmid:10455940
|
Ringe B et al. |
Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11120285
|
Birk PE et al. |
Preliminary experience with FK 506 in pediatric renal transplant recipients: a single-center report. |
1996 |
Transplant. Proc. |
pmid:8623493
|
Alloway RR et al. |
Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. |
1996 |
Transplant. Proc. |
pmid:8623494
|
Dumont FJ et al. |
Up-regulation of gene expression by FK 506. |
1991 |
Transplant. Proc. |
pmid:1721300
|
Takara T et al. |
Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506. |
1994 |
Transplant. Proc. |
pmid:7518150
|
Koefoed-Nielsen PB et al. |
Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients. |
2005 |
Transplant. Proc. |
pmid:15919449
|
Kusne S et al. |
Infectious complications after small bowel transplantation in adults. |
1994 |
Transplant. Proc. |
pmid:7518153
|
Akioka K et al. |
Abdominal pain is a critical complication of mycophenolate mofetil in renal transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12591411
|
Jain A et al. |
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. |
1992 |
Transplant. Proc. |
pmid:1376518
|
Watanabe K et al. |
Factors influencing long-term operational tolerance in dogs treated with fractionated lymphoid irradiation, donor bone marrow cell infusion and FK506. |
1995 |
Transplant. Proc. |
pmid:7533389
|
Kitamura T et al. |
Severe hemolytic anemia related to production of cold agglutinins following living donor liver transplantation: a case report. |
2003 |
Transplant. Proc. |
pmid:12591458
|
Masutani H et al. |
Suppression of the histologic changes of GVHD by FK 506 in rat small bowel transplantation. |
1992 |
Transplant. Proc. |
pmid:1376519
|
Wennberg L et al. |
Efficacy of various immunosuppressive drugs in preventing pig-to-rat islet xenograft rejection. |
1995 |
Transplant. Proc. |
pmid:7533391
|
Borg AJ and Kumagai M |
FK 506 and xenogeneic human anti-porcine cellular reactivity. |
1991 |
Transplant. Proc. |
pmid:1721332
|
Fung J et al. |
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721333
|
Jain A et al. |
Steroid withdrawal under tacrolimus for primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis after liver transplantation and long-term survival. |
2002 |
Transplant. Proc. |
pmid:12176467
|
Lladó L et al. |
Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy. |
2002 |
Transplant. Proc. |
pmid:12176468
|
Fleck PR et al. |
Tacrolimus use in kidney-pancreas recipients is associated with less acute renal dysfunction than cyclosporine. |
1998 |
Transplant. Proc. |
pmid:9865299
|
Niel OR et al. |
Long-term glomerular filtration rate in liver allograft recipients according to the type of calcineurin inhibitors. |
2009 |
Transplant. Proc. |
pmid:19857743
|
Regazzi MB et al. |
Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. |
1997 |
Transplant. Proc. |
pmid:9142302
|
Rifai K et al. |
Severe hearing loss after liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919504
|
Oltean M et al. |
FK506 donor pretreatment improves intestinal graft microcirculation and morphology by concurrent inhibition of early NF-kappaB activation and augmented HSP72 synthesis. |
2005 |
Transplant. Proc. |
pmid:15919508
|
Lemster B et al. |
Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. |
1992 |
Transplant. Proc. |
pmid:1281576
|
Jensen CW et al. |
Pediatric renal transplantation under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721364
|
Solà R et al. |
Tacrolimus in induction immunosuppressive treatment in renal transplantation: comparison with cyclosporine. |
2003 |
Transplant. Proc. |
pmid:12962763
|
Pascual J et al. |
Comparison between a two-drug regimen with tacrolimus and steroids and a triple one with azathioprine in kidney transplantation: results of a European trial with 3-year follow up. |
2003 |
Transplant. Proc. |
pmid:12962764
|
Ciancio G et al. |
Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176508
|
Charpentier B |
A three arm study comparing immediate tacrolimus therapy with ATG induction therapy followed by either tacrolimus or cyclosporine in adult renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176511
|
Deuse T et al. |
Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection? |
2007 |
Transplant. Proc. |
pmid:17362784
|
Yura H et al. |
Development of a macromolecular prodrug of FK506: I. Synthesis of FK506-dextran conjugate. |
1998 |
Transplant. Proc. |
pmid:9838577
|
Soylu H et al. |
Survival of renal transplant patients: data from a tertiary care center in Turkey. |
2015 |
Transplant. Proc. |
pmid:25769571
|
Yamauchi M et al. |
Effects of FK506 on rat thymic microenvironment in thymocyte maturation, proliferation, and mobilization. |
1998 |
Transplant. Proc. |
pmid:9838578
|
Kato T et al. |
Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083158
|
Watanabe K et al. |
Prolongation effect of FK506 on the survival of 3-day preserved kidney allografts in dogs. |
1998 |
Transplant. Proc. |
pmid:9838579
|
Mueller AR et al. |
Is the use of marginal liver grafts justified? |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083160
|
Karakulska-Prystupiuk E et al. |
Pericarditis in Patients With Chronic Graft-vs-Host Disease. |
2018 |
Transplant. Proc. |
pmid:30177139
|
Takeuchi H et al. |
Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level. |
2008 |
Transplant. Proc. |
pmid:18790203
|
Morozumi K et al. |
Electron-microscopic peritubular capillary lesion is a specific and useful diagnostic indicator for chronic rejection of renal allografts showing less specific morphologic lesions in the cyclosporine era. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123167
|
Morris RE et al. |
Immunopharmacology of FK-506. |
1989 |
Transplant. Proc. |
pmid:2468201
|
Zipperle S et al. |
Impaired T-cell IL-10 secretion and CD4 helper function in liver transplant patients treated with tacrolimus. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123208
|
Carroll PB et al. |
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. |
1991 |
Transplant. Proc. |
pmid:1721396
|
Freise CE et al. |
Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. |
1991 |
Transplant. Proc. |
pmid:1721397
|
McGrath JS and Shehata M |
The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection. |
2001 |
Transplant. Proc. |
pmid:11377499
|
Koefoed-Nielsen PB and Jørgensen KA |
Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176559
|
Gasser M et al. |
Putative regulatory function of alloreactive Th2 cells in tolerant recipients after small bowel transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266759
|
Jiang H et al. |
Inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083538
|
Kahan BD |
High variability of drug exposure: a biopharmaceutic risk factor for chronic rejection. |
1998 |
Transplant. Proc. |
pmid:9723224
|
Sheng H et al. |
Ocular complications of heart transplantation in a Chinese population. |
2008 |
Transplant. Proc. |
pmid:19100445
|
Yamada MF et al. |
Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis. |
2008 |
Transplant. Proc. |
pmid:19100456
|
Dresske B et al. |
Synergistic impact of "WOFIE" on the immunosuppressive potency of FK 506 in a heterotopic heart transplantation model in the rat. |
1999 |
Transplant. Proc. |
pmid:10331001
|
Lauro A et al. |
Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning? |
2005 |
Transplant. Proc. |
pmid:15964382
|
Jiménez-Pérez M et al. |
Everolimus plus mycophenolate mofetil as initial immunosuppression in liver transplantation. |
|
Transplant. Proc. |
pmid:25645779
|
Fukuzawa M et al. |
Effect of donor-specific transfusion and FK 506 on small intestine allotransplantation. |
1991 |
Transplant. Proc. |
pmid:1721427
|
Park KM et al. |
Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. |
1996 |
Transplant. Proc. |
pmid:8658863
|
Ogasa N et al. |
Effect of FK 506 on growth of transplanted newborn rat intestine. |
1991 |
Transplant. Proc. |
pmid:1721428
|
Trotter JF |
Sirolimus in liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12742496
|
MacDonald AS |
Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation. |
2003 |
Transplant. Proc. |
pmid:12742497
|
Ojogho ON et al. |
Mycophenolate mofetil without antibody induction in pediatric renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176641
|
Sindhi R et al. |
Pharmacodynamics of sirolimus in transplanted children receiving tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176644
|
Quiroga I et al. |
Differential homocysteine levels in renal transplant patients receiving neoral versus tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267261
|
Slatinska J et al. |
Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience. |
2013 |
Transplant. Proc. |
pmid:23726604
|
Chakrabarti P et al. |
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267274
|
Grabczewska Z et al. |
Neither cyclosporine nor tacrolimus deteriorate endothelial function in renal transplant recipients assessed with reactive hyperernia index. |
2013 |
Transplant. Proc. |
pmid:23726621
|
Yonan NA et al. |
Tracheal allograft transplantation in rats: the role of immunosuppressive agents in development of obliterative airway disease. |
1998 |
Transplant. Proc. |
pmid:9723443
|
Greenstein SM et al. |
Nifedipine prevents tacrolimus-induced intestinal hemodynamic and functional impairments. |
1998 |
Transplant. Proc. |
pmid:9745540
|
Xu M et al. |
FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation. |
1998 |
Transplant. Proc. |
pmid:9723447
|
Maroun T et al. |
Rejection therapy with tacrolimus in renal transplantation: preliminary results of a collaborative multicenter study in 45 patients. Groupe Cooperatif de Transplantation D'ile de France (GCIF). |
1998 |
Transplant. Proc. |
pmid:9745576
|
MartÃn-Fernández M et al. |
Effects of Cyclosporine, Tacrolimus, and Rapamycin on Osteoblasts. |
2017 |
Transplant. Proc. |
pmid:29149986
|
Fung JJ and Starzl TE |
FK 506 in solid organ transplantation. |
1994 |
Transplant. Proc. |
pmid:7524226
|
McCauley J et al. |
FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. |
1991 |
Transplant. Proc. |
pmid:1721459
|
Griffin AD et al. |
FK 506 in canine renal transplantation. |
1992 |
Transplant. Proc. |
pmid:1384209
|
Garcia CD et al. |
Pediatric renal transplantation under tacrolimus or cyclosporine immunosuppression and basiliximab induction. |
2002 |
Transplant. Proc. |
pmid:12431513
|
Owen ER et al. |
Peripheral nerve regeneration in human hand transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267484
|
Shullo MA et al. |
Elevated tacrolimus levels associated with intravenous azithromycin and ceftriaxone: a case report. |
2010 |
Transplant. Proc. |
pmid:20620540
|
Stempfle HU et al. |
Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636459
|
Marcus N et al. |
Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636460
|
Filler G |
Optimization of immunosuppressive drug monitoring in children. |
2007 |
Transplant. Proc. |
pmid:17524944
|
Hildebrandt A et al. |
FK 506: short- and long-term treatment after cardiac transplantation in nonhuman primates. |
1991 |
Transplant. Proc. |
pmid:1703694
|
Ericzon BG et al. |
Effect of FK 506 on glucose metabolism in the cynomolgus monkey: studies in pancreatic transplant recipients and nontransplanted animals. |
1991 |
Transplant. Proc. |
pmid:1703695
|